Edition:
United States

Theravance Inc (THRX.OQ)

THRX.OQ on NASDAQ Stock Exchange Global Select Market

--USD
--
Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
204,359
52-wk High
$14.09
52-wk Low
$6.72

THRX.OQ

Chart for THRX.OQ

About

Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including... (more)

Overall

Beta: 2.00
Market Cap(Mil.): $1,222.12
Shares Outstanding(Mil.): 111.20
Dividend: 0.25
Yield (%): 9.10

Financials

  THRX.OQ Industry Sector
P/E (TTM): 71.22 36.21 36.19
EPS (TTM): 0.15 -- --
ROI: 4.61 14.41 13.87
ROE: -- 15.21 14.78

Earnings vs. Estimates